Abbott, GSK to develop screening test for lung cancer antigen

07/13/2009 | Forbes

Abbott Laboratories and GlaxoSmithKline are teaming up to develop a molecular diagnostic test that screens for the MAGE-A3 antigen found in nonsmall-cell lung cancer tumors. The partnership comes as GSK works on the late-stage development of a drug that targets the MAGE-A3 protein.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN